Abstract
Background: Lower urinary tract symptoms are very common in older men and affect patients’ quality of life as well as increase medical costs, most often caused by benign prostatic hyperplasia. One of the consequences of benign prostatic hyperplasia is the bladder outlet obstruction, causing lower urinary tract symptoms (LUTS) and affecting the urinary flow rate; affecting the detrusor muscle, increased post void residual urine (PVR). Objectives: To investigate the clinical characteristics and correlation between the severity of symptoms according to IPSS with some factors such as urinary flow rate, prostate volume, intravesical prostatic protrusion (IPP), post void residual urine (PVR); correlation between prostate volume and urinary flow rate in patients of benign prostatic hyperplasia with lower urinary tract symptoms. Materials and methods: A cross-sectional descriptive study in 97 patients of benign prostatic hyperplasia with lower urinary tract symptoms who came to the Hospital of Hue University of Medicine and Pharmacy from September 2022 to March 2023. All patients in the study were surveyed about clinical symptoms, assessed the severity of symptoms according to IPSS, some suprapubic ultrasound characteristics of the prostate gland and uroflowmetry. At the same time, evaluate the correlation between the IPSS with a number of factors such as urinary flow rate, prostate volume, intravesical prostatic protrusion, post voiding residual urine; correlation between prostate volume on ultrasound and urinary flow rate. Results: The most common group of lower urinary tract symptoms was the voiding symptoms (97.9%), the group of storage and postmicturition symptoms also accounted for a high proportion (96.9% and 86.6%). The majority of patients had symptoms of all three symptom groups (82.5%). The most common symptom is weak urine stream (85.6%). Most of the patients had moderate (52.6%) and severe (42.3%). The mean IPSS was 17.4 ± 5.2 and the QoL was 3.9 ± 1.0. There was a negative correlation between IPSS and maximum flow rate Qmax (r = -0.535, p < 0.05), and average flow rate Qave (r = -0.488, p < 0.05). There was a positive correlation between IPSS with intravesical prostatic protrusion (r = 0.381; p < 0.05) and post voiding residual urine volume PVR (r = 0.397; p < 0.05). There was no correlation between prostate volume and maximum flow rate Qmax (r = -0.067, p > 0.05) and average flow rate Qave (r = -0.135, p>0.05). Conclusion: Urinary weakness and voiding symptoms were the most common in patients with benign prostatic hyperplasia. The majority of patients have moderate to severe symptoms. There is a negative correlation between IPSS with maximum urinary flow rate and average urinary flow rate. There is a positive correlation between IPSS with intravesical prostatic protrusion and post void residual urinary volume. There is no correlation between prostate volume and maximum flow rate and mean flow rate.
Published | 2025-06-25 | |
Fulltext |
|
|
Language |
|
|
Issue | Vol. 15 No. 3 (2025) | |
Section | Original Articles | |
DOI | 10.34071/jmp.2025.3.27 | |
Keywords | triệu chứng đường tiểu dưới, tăng sinh lành tính tuyến tiền liệt, IPSS, tốc độ dòng tiểu, thể tích tuyến tiền liệt benign prostatic hyperplasia, lower urinary tract symptoms, international prostate symptom score IPSS, uroflow rate, prostate volume, intravesical prostatic protrusion (IPP), post void residual urine (PVR) |

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Hue Journal of Medicine and Pharmacy
Cornu JN, Gacci M, Hashim H, Herrmann TRW, Malde S, Netsch C, et al. Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). European Association of Urology. 2023:5-6.
Knight L, Dale M, Cleves A, Pelekanou C, Morris R. UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update. Applied health economics and health policy. 2022;20(5):669-80.
G. B. D. Benign Prostatic Hyperplasia Collaborators. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Healthy Longev. 2022;3(11):e754-e76.
Oesterling JE. The Origin and Development of Benign Prostatic Hyperplasia: An Age-Dependent Process. Journal of Andrology. 1991;12(6):350-1.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37-49.
Awaisu M, Ahmed M, Lawal AT, Sudi A, Tolani MA, Oyelowo N, et al. Correlation of prostate volume with severity of lower urinary tract symptoms as measured by international prostate symptoms score and maximum urine flow rate among patients with benign prostatic hyperplasia. African Journal of Urology. 2021;27(1):16.
Goyal M, Dobhal D, Tyagi P, Goyal SK. To Know the Correlation of Prostate Size on Ultrasound with International Prostate Symptom Score and Uroflowmetry in Benign Prostatic Hyperplasia. International Journal of Scientific Study. 2020;8(3):52-8.
Đinh Văn Tài. Nghiên cứu đặc điểm các triệu chứng đường tiểu dưới và nồng độ kháng nguyên đặc hiệu tuyến tiền liệt (PSA) ở bệnh nhân phì đại tuyến tiền liệt [Luận văn Bác sĩ đa khoa]: Đại học Y Dược Huế; 2022.
Nguyễn Khoa Hùng, Lê Đình Khánh, Võ Minh Nhật. Nghiên cứu chỉ định và kết quả đo niệu dòng đồ tại phòng khám ngoại tiết niệu. Tạp chí Y học thành phố Hồ Chí Minh. 2015;19(4):302-8.
Võ Đoàn Minh Nhật. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và thái độ xử trí tăng sinh lành tính tuyến tiền liệt [Luận văn Bác sĩ đa khoa]: Đại học Y Dược Huế; 2017.
Safaa Hussein Ibrahim Hamid, Ali Yasen Mohamedahmed, Abdel Raof Sharfi. Correlation between the Size of the Prostate, Post Void Residual Volume, PSA Level and IPSS in Men with LUTS in Three Major Urology Centers in Khartoum. International Journal of Surgical Research. 2020;9(1):1-8.
Nguyễn Thị Mỹ. Nghiên cứu mối liên quan giữa chỉ số SPSS, thể tích tuyến tiền liệt, một số chỉ số niệu động học ở bệnh nhân tăng sinh lành tính tuyến tiền liệt [Luận văn Bác sĩ đa khoa]: Đại học Y Dược Huế; 2013.
Nguyễn Đặng Đình Thi. Khảo sát sự tương quan giữa sự cải thiện triệu chứng lâm sàng với khối lượng mô tuyến được cắt ở bệnh nhân phì đại lành tính tuyến tiền liệt [Luận văn Thạc sĩ Y học]: Đại học Y Dược Huế; 2011.
Landry Oriole Mbouché, Achille Aurèle Mbassi, Frantz Guy Epoupa Ngallè, Forbang Ako, Axel Stéphane Nwaha Makon, Boniface Moifo, et al. Correlation between the International Prostate Symptom Score, Ultrasound Features and Maximum Flow Rate in Cameroonian Patients with Benign Prostatic Hypertrophy. Open Journal of Urology. 2022;12(1):37-50.
Singla S, Garg R, Singla A, Sharma S, Singh J, Sethi P. Experience with uroflowmetry in evaluation of lower urinary tract symptoms in patients with benign prostatic hyperplasia. Journal of clinical and diagnostic research : JCDR. 2014;8(4):Nc01-3.
Garg A, Bansal S, Saha S, Kumar A. Study of correlation of urodynamic profile with symptom scoring and ultrasonographic parameters in patients with benign prostatic hyperplasia. 2020;9(1):215-20.
Vesely S, Knutson T, Damber J-E, Dicuio M, Dahlstrand C. Relationship Between Age, Prostate Volume, Prostate-specific Antigen, Symptom Score and Uroflowmetry in Men with Lower Urinary Tract Symptoms. Scandinavian Journal of Urology and Nephrology. 2003;37(4):322-8.
Rosier PFWM, de la Rosette JJMCH. Is there a correlation between prostate size and bladder-outlet obstruction? World journal of urology. 1995;13(1):9-13.
Bosch JL, Hop WC, Kirkels WJ, Schröder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. British journal of urology. 1995;75(5):622-30.
Sundaram D, Sankaran PK, Raghunath G, Vijayalakshmi S, Vijayakumar J, Yuvaraj MF, et al. Correlation of Prostate Gland Size and Uroflowmetry in Patients with Lower Urinary Tract Symptoms. Journal of clinical and diagnostic research : JCDR. 2017;11(5):Ac01-ac4.